retatrutide argentina Premium Costa Rica New weight-loss drug Retatrutide showing

Eligibility for our compounded GLP-1 program is based on BMI and clinical criteria reviewed by a licensed provider

If you experience a related symptom, treat it as an emergency

We keep the catalog focused and present batch-level standards clearly so quality, consistency, and transparency stay close to the buying decision

In the SURMOUNT-1 trial , participants receiving the highest dose of Tirzepatide achieved average body weight reductions of 20.9% over 72 weeks, compared to the 14.9% reduction observed with Semaglutide in the STEP-1 trial

At a time when weight care was highly stigmatized and few comprehensive telehealth solutions existed, Found saw an opportunity to transform how people access and experience weight management. At a time when weight care was highly stigmatized and few comprehensive telehealth solutions existed, Found saw an opportunity to transform how people access and experience weight management Since 2019, Found has had more than 250,000 members